Navigation Links
Charcot-marie-tooth disease research funding
Date:7/10/2008

WILLIAMSTOWN, Mass., July 10, 2008 -- The National Institutes of Health (NIH) has awarded a two-year grant of $220,076 to Williams College Assistant Professor of Biology Lara D. Hutson, in support of her research on Charcot-Marie-Tooth disease or CMT.

CMT is the most common inherited neuromuscular disease, affecting as many as one in every 2,500 individuals. CMT usually shows dominant inheritance and symptoms generally appear during adolescence or young adulthood. It is characterized by degeneration of long motor and sensory axons, which results in muscle atrophy and skeletal deformities.

Hutson's research will use zebrafish as a model system to investigate disease mutations in two small heat shock proteins, HSP27 and HSPB8, which can cause either CMT or the closely related disease Distal Hereditary Motor Neuropathy (dHMN). The results of these studies will help to better understand the cell biological events leading to axon degeneration in CMT and dHMN.

Since these diseases are likely determined, at least in part, by environmental factors, the results of these studies could have implications for the prevention and management of these diseases.

Hutson's primary research has been published in a number of prestigious scientific journals, including Neuron and Gene, as well as the compendium "The Zebrafish: Cellular and Developmental Biology." This is her third NIH grant award.


'/>"/>

Contact: Jo Procter
Jo.Procter@williams.edu
413-597-4279
Williams College
Source:Eurekalert

Page: 1

Related biology news :

1. Hepatitis C virus may need enzymes help to cause liver disease
2. Insect warning colors aid cancer and tropical disease drug discovery
3. The first autism disease genes
4. Healthy or diseased?
5. The benefits of green tea in reducing an important risk factor for heart disease
6. Fungi the cause of many outbreaks of disease but mostly ignored
7. The Parkinsons Disease Foundation awards $950,000 in seed grants
8. Montreal Heart Institute and Mount Sinai Hospital researchers contribute to Crohns disease study
9. Bee disease a mystery
10. Complexity of Crohns disease revealed as gene count tops 30
11. UIC researchers make promising finding in severe lung disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
(Date:3/16/2017)... Germany , March 16, 2017 CeBIT 2017 - Against identity ... Continue Reading ... Used combined in one project, multi-biometric solutions provide ... Used ... Systems) ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... animal blood plasma products and derivatives market is fragmented due to the ... large players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, ... clear leader, these three companies, collectively, held more than 76% of ... ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer ... hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. ... development activities. , “Dr. Floyd’s career has spanned 30 years in the chemicals ...
(Date:3/22/2017)... , March 22, 2017  Ascendis Pharma A/S ... innovative TransCon technology to address significant unmet medical ... for the full year ended December 31, 2016. ... for our company as we broadened our pipeline ... integrated rare disease company with an initial focus ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
Breaking Biology Technology: